Soper Stanley E

Senior Vice President and CLONUTRACEUTICAL INTERNATIONAL CORP (NUTR) · full profile →Form 4 · filed Aug 24, 2017
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 23, 2017Disposed to issuer(D)19K0
Aug 23, 2017Disposed to issuer(D)5K0
Aug 23, 2017Disposed to issuer(D)1K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 23, 2017Disposed to issuer(D)15K$41.80$614K0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001396677-17-000032) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about NUTR insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001396677-17-000032"
Ask your agent
Use Arkolith to summarize insider buying and selling at NUTRACEUTICAL INTERNATIONAL CORP
over the last 90 days and cite the filings.